Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
49.92
+0.96 (1.96%)
At close: Mar 28, 2025, 2:57 PM CST

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
22,14417,23719,53016,03014,959-
Upgrade
Market Cap Growth
-11.74%-11.74%21.83%7.16%--
Upgrade
Enterprise Value
22,24817,34218,89114,51814,805-
Upgrade
Last Close Price
53.0241.4747.8539.3737.01-
Upgrade
PS Ratio
60.8947.83213.94-1454.37-
Upgrade
PB Ratio
51.4439.4223.019.126.07-
Upgrade
P/TBV Ratio
--50.5112.667.53-
Upgrade
EV/Sales Ratio
61.7348.12206.94-1439.37-
Upgrade
Debt / Equity Ratio
2.072.070.480.050.04-
Upgrade
Asset Turnover
--0.05-0.010.03
Upgrade
Inventory Turnover
--0.54---
Upgrade
Quick Ratio
--1.785.709.825.88
Upgrade
Current Ratio
--2.035.939.966.06
Upgrade
Return on Equity (ROE)
-133.26%-133.26%-84.98%-34.87%-37.83%-76.72%
Upgrade
Return on Assets (ROA)
---40.35%-20.52%-21.46%-52.76%
Upgrade
Return on Capital (ROIC)
-45.77%-45.77%-46.54%-22.54%-23.23%-62.42%
Upgrade
Earnings Yield
-3.87%-4.97%-5.67%-4.59%-4.48%-
Upgrade
FCF Yield
--5.12%-4.22%-3.35%-
Upgrade
Buyback Yield / Dilution
-1.63%-1.63%-0.70%-12.29%-0.07%-
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.